Melbourne, Australia

Clinuvel Pharmaceuticals Limited


USPTO Granted Patents = 8



Trademarks = 3

Forward Citations = 6

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Michael John Kleinig (4 out of 6 patents)

silverMedal Thomas R Tice (3 out of 49 patents)

bronzeMedal Jay K Staas (3 out of 16 patents)

4 Philippe Wolgen (3 out of 3 patents)

5 Berno I Pettersson, Jr (1 out of 3 patents)

6 Stuart Michael Humphrey (1 out of 1 patent)

7 Kenneth B Kirby (1 out of 4 patents)

8 Thomas A Luger (5 patents)

9 Karin Loser (1 patent)

10 Berno I Pettersson (0 patent)

11 Jr Berno I Pettersson (0 patent)

12 Stuart Michael Humphrey (0 patent)


8 patents:

Clinuvel Pharmaceuticals Limited is a global biopharmaceutical company focused on developing and commercializing treatments for patients with a range of severe genetic and skin disorders. The company's lead product, SCENESSE, is approved in Europe and Australia for the treatment of EPP, a rare genetic disorder causing severe phototoxic reactions to sunlight. Clinuvel's mission is to improve the quality of life for patients suffering from life-threatening and debilitating disorders.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#20 in Melbourne

#482 in Australia

...
Melbourne, Australia
Forward Citations = 6

16 inventors:

Please report any incorrect information to support@idiyas.com
Loading…